Protein S
Latest Information Update: 13 Jan 2022
At a glance
- Originator Hyland Immuno
- Class Anticoagulants
- Mechanism of Action Protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 22 Sep 1998 No-Development-Reported for Thrombosis in Austria (Injection)
- 25 Oct 1995 Preclinical development for Thrombosis in Austria (Injection)
- 16 Aug 1995 New profile